Membranous Nephropathy: From Research Bench to Personalized Care

• Main Authors: Barbara Moszczuk, Krzysztof Kiryluk, Leszek Pączek, Krzysztof Mucha
• Format: Article
• Language: English
• Published: MDPI AG 2021-03-01
• Series: Journal of Clinical Medicine
• Subjects: membranous nephropathy; glomerulonephritis; personalized medicine; PLA₂R; proteomics
• Online Access: https://www.mdpi.com/2077-0383/10/6/1205

Membranous nephropathy is a glomerulopathy that causes nephrotic syndrome and, in at least a third of cases, lasting end-stage kidney disease (ESKD). It is also a rare case of revolutionary changes in our understanding of the disease, that translates from scientific findings to real diagnosis and treatment recommendations in less than ten years. In this review we present: (1) a short history and traditional approach to patients with membranous nephropathy, (2) current recommendations and treatment options that have emerged in recent years, (3) findings of new studies, with a particular focus on serological/immunological methods, genomic and proteomic studies, still requiring validation. With further development in this field, membranous nephropathy may become one of the first nephrological conditions that apply a truly personalized approach with the omission of invasive measures such as kidney biopsy.